NCT00006434View on ClinicalTrials.gov

Tumor Lysate Pulsed-Dendritic Cell Vaccines After High-Dose Chemotherapy for Non-Hodgkin's Lymphoma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Lymphoma, Non-Hodgkin
Interventions
BIOLOGICAL

tumor-pulsed dendritic cells

Trial Locations (1)

48104-0914

University of Michigan Medical Center, Ann Arbor

All Listed Sponsors
lead

National Center for Research Resources (NCRR)

NIH

NCT00006434 - Tumor Lysate Pulsed-Dendritic Cell Vaccines After High-Dose Chemotherapy for Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter